Etoposide Capsule

DRUG2 trials

Sponsors

Mingzhi Zhang, Indiana University

Conditions

ALK-Positive Anaplastic Large Cell LymphomaGerm Cell Tumor

Phase 1

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

RecruitingNCT06937866

Indiana UniversityGerm Cell Tumor

Start: 2025-11-12End: 2031-09-30Target: 38Updated: 2025-11-21

Phase 4

Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL

Mingzhi ZhangALK-Positive Anaplastic Large Cell Lymphoma

Start: 2018-10-01End: 2021-02-01Target: 20Updated: 2018-10-16